Safety of TY027, a Treatment for COVID-19, in Humans

NCT04429529 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tychan Pte Ltd.